Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Therma Bright Inc (THRM.VN)

Therma Bright Inc (THRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 4,060
  • Shares Outstanding, K 58,003
  • Annual Sales, $ 80 K
  • Annual Income, $ -4,343 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.26
  • Price/Sales 53.00
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings $0.00 on 12/22/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Medical Devices

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.050 +40.00%
on 03/19/26
0.075 -6.67%
on 03/31/26
+0.010 (+16.67%)
since 02/27/26
3-Month
0.050 +40.00%
on 03/19/26
0.080 -12.50%
on 01/20/26
+0.020 (+40.00%)
since 12/23/25
52-Week
0.045 +55.56%
on 12/19/25
0.240 -70.83%
on 04/02/25
-0.170 (-70.83%)
since 03/28/25

Most Recent Stories

More News
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually

Therma Bright Builds on Revenue Progress with Initial 100-Unit Venowave™ Order; Signals Expansion into Cosmetic Wellness MarketToronto, Ontario--(Newsfile Corp. - March 31, 2026) - Therma Bright Inc....

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial

Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med

Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma Bright" or the "Company"), a developer and investment partner specializing in...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma"...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors

Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner in advanced diagnostic...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales

Initial 200-Unit Sale previously announced on April 24, 2025, Targeted Specialized Knee Surgeons in U.S. Healthcare NetworkToronto, Ontario--(Newsfile Corp. - September 24, 2025) - Therma Bright Inc. (TSXV:...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Proposes to Amend Certain Warrants

Toronto, Ontario--(Newsfile Corp. - August 28, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma Bright" or the "Company") announces that subject to the approval of the TSX Venture...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Announces Share Consolidation

Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company") announces, further to its news release dated June 11, 2025,...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Inc. Announces Share Consolidation

Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner specializing in advanced...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements

Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company") a developer and investment partner specializing in advanced...

THRM.VN : 0.070 (+7.69%)
TBRIF : 0.0380 (-5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing...

See More

Key Turning Points

3rd Resistance Point 0.085
2nd Resistance Point 0.080
1st Resistance Point 0.075
Last Price 0.070
1st Support Level 0.065
2nd Support Level 0.060
3rd Support Level 0.055

See More

52-Week High 0.240
Fibonacci 61.8% 0.166
Fibonacci 50% 0.142
Fibonacci 38.2% 0.119
Last Price 0.070
52-Week Low 0.045

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.